JP2022521787A5 - - Google Patents

Info

Publication number
JP2022521787A5
JP2022521787A5 JP2021549970A JP2021549970A JP2022521787A5 JP 2022521787 A5 JP2022521787 A5 JP 2022521787A5 JP 2021549970 A JP2021549970 A JP 2021549970A JP 2021549970 A JP2021549970 A JP 2021549970A JP 2022521787 A5 JP2022521787 A5 JP 2022521787A5
Authority
JP
Japan
Prior art keywords
item
cells
donor dna
nucleotides
population
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
JP2021549970A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022521787A (ja
Filing date
Publication date
Priority claimed from US16/288,052 external-priority patent/US20200224160A1/en
Application filed filed Critical
Publication of JP2022521787A publication Critical patent/JP2022521787A/ja
Publication of JP2022521787A5 publication Critical patent/JP2022521787A5/ja
Priority to JP2024219750A priority Critical patent/JP2025061660A/ja
Ceased legal-status Critical Current

Links

JP2021549970A 2018-02-27 2020-02-27 Rna誘導型エンドヌクレアーゼを使用するdna組み込みのための改善された方法 Ceased JP2022521787A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2024219750A JP2025061660A (ja) 2018-02-27 2024-12-16 Rna誘導型エンドヌクレアーゼを使用するdna組み込みのための改善された方法

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201862635702P 2018-02-27 2018-02-27
US16/288,052 US20200224160A1 (en) 2018-02-27 2019-02-27 Process for dna integration using rna-guided endonucleases
US16/288,052 2019-02-27
PCT/US2020/020121 WO2020176740A1 (en) 2018-02-27 2020-02-27 Improved process for dna integration using rna-guided endonucleases

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2024219750A Division JP2025061660A (ja) 2018-02-27 2024-12-16 Rna誘導型エンドヌクレアーゼを使用するdna組み込みのための改善された方法

Publications (2)

Publication Number Publication Date
JP2022521787A JP2022521787A (ja) 2022-04-12
JP2022521787A5 true JP2022521787A5 (cg-RX-API-DMAC7.html) 2023-03-07

Family

ID=71516309

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2021549970A Ceased JP2022521787A (ja) 2018-02-27 2020-02-27 Rna誘導型エンドヌクレアーゼを使用するdna組み込みのための改善された方法
JP2024219750A Pending JP2025061660A (ja) 2018-02-27 2024-12-16 Rna誘導型エンドヌクレアーゼを使用するdna組み込みのための改善された方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2024219750A Pending JP2025061660A (ja) 2018-02-27 2024-12-16 Rna誘導型エンドヌクレアーゼを使用するdna組み込みのための改善された方法

Country Status (11)

Country Link
US (2) US20200224160A1 (cg-RX-API-DMAC7.html)
EP (1) EP3931322A1 (cg-RX-API-DMAC7.html)
JP (2) JP2022521787A (cg-RX-API-DMAC7.html)
KR (1) KR20210134000A (cg-RX-API-DMAC7.html)
CN (1) CN113906136A (cg-RX-API-DMAC7.html)
AU (1) AU2020229848A1 (cg-RX-API-DMAC7.html)
CA (1) CA3131588A1 (cg-RX-API-DMAC7.html)
IL (1) IL285842A (cg-RX-API-DMAC7.html)
MX (1) MX2021010322A (cg-RX-API-DMAC7.html)
SG (1) SG11202109332RA (cg-RX-API-DMAC7.html)
WO (1) WO2020176740A1 (cg-RX-API-DMAC7.html)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3204496A1 (en) 2014-10-10 2017-08-16 Editas Medicine, Inc. Compositions and methods for promoting homology directed repair
KR20200124702A (ko) 2018-02-23 2020-11-03 파이어니어 하이 부렛드 인터내쇼날 인코포레이팃드 신규한 cas9 오르소로그
CN113166744B (zh) 2018-12-14 2025-02-07 先锋国际良种公司 用于基因组编辑的新颖crispr-cas系统
KR20210133261A (ko) * 2019-02-26 2021-11-05 소렌토 쎄라퓨틱스, 인코포레이티드 Bcma에 결합하는 항원 결합 단백질
KR20210137085A (ko) 2019-03-05 2021-11-17 엔카르타, 인크. Cd19 유도된 키메라 항원 수용체 및 면역 요법에서 이의 용도
SG11202113253SA (en) 2019-06-07 2021-12-30 Scribe Therapeutics Inc Engineered casx systems
EP4139345A1 (en) 2020-04-24 2023-03-01 Sorrento Therapeutics, Inc. Memory dimeric antigen receptors
WO2022015956A1 (en) 2020-07-15 2022-01-20 Sorrento Therapeutics, Inc. Improved process for dna integration using rna-guided endonucleases
AU2021320556A1 (en) * 2020-08-07 2023-03-09 Neogene Therapeutics B.V. Methods to enrich genetically engineered T cells
AU2021378791A1 (en) * 2020-11-11 2023-06-15 Monsanto Technology Llc Methods to improve site-directed integration frequency
AU2021392719B2 (en) 2020-12-03 2025-08-14 Scribe Therapeutics Inc. Engineered class 2 type v crispr systems
WO2022215978A1 (ko) * 2021-04-05 2022-10-13 주식회사 셀렌진 Pdcd-1 유전자에 상보적인 가이드 rna 및 이의 용도
US20260000702A1 (en) 2024-06-26 2026-01-01 Flagship Pioneering Innovations Vii, Llc Therapeutic circular dna forms
WO2026020171A2 (en) 2024-07-19 2026-01-22 Aera Therapeutics, Inc. Chimeric antigen receptor constructs

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6010907A (en) * 1998-05-12 2000-01-04 Kimeragen, Inc. Eukaryotic use of non-chimeric mutational vectors
US6556674B1 (en) 1998-11-19 2003-04-29 Legerity, Inc. Signal detector with matched filter coefficient
US9957515B2 (en) * 2013-03-15 2018-05-01 Cibus Us Llc Methods and compositions for targeted gene modification
JP6608807B2 (ja) * 2013-05-29 2019-11-20 セレクティス Rnaガイドcasヌクレアーゼ系を用いることによって免疫療法のためにt細胞を操作するための方法
WO2017070429A1 (en) * 2015-10-22 2017-04-27 Regents Of The University Of Minnesota Methods involving editing polynucleotides that encode t cell receptor
KR102614675B1 (ko) * 2016-04-15 2023-12-19 메모리얼 슬로안 케터링 캔서 센터 유전자이식 t 세포 및 키메라 항원 수용체 t 세포 조성물 및 관련 방법
EP3872177B1 (en) * 2016-05-27 2025-11-26 Life Technologies Corporation Compositions and methods for enhancing homologous recombination
WO2018023631A1 (zh) * 2016-08-04 2018-02-08 汤隆初 自动浇水技术的使用情况反馈方法以及自动浇水装置
WO2018073391A1 (en) * 2016-10-19 2018-04-26 Cellectis Targeted gene insertion for improved immune cells therapy
JP2020534813A (ja) * 2017-09-08 2020-12-03 ライフ テクノロジーズ コーポレイション 改良された相同組換えおよびその組成物のための方法
EP3781677A4 (en) * 2018-04-16 2022-01-19 University of Massachusetts COMPOSITIONS AND METHODS FOR IMPROVED GENE EDITTING

Similar Documents

Publication Publication Date Title
JP7579820B2 (ja) 化学修飾を有するガイドrna
KR102738283B1 (ko) 암 면역요법을 위한 crispr-cpf1-관련 방법, 조성물 및 구성성분
ES2884838T3 (es) ARN guía químicamente modificados para la regulación génica mediada por CRISPR/CAS
US10526590B2 (en) Compounds and methods for CRISPR/Cas-based genome editing by homologous recombination
JP6835726B2 (ja) Crisprハイブリッドdna/rnaポリヌクレオチドおよび使用方法
AU2024259841A1 (en) CRISPR-Cas-related methods, compositions and components for cancer immunotherapy
JP2022137068A (ja) 化学的に修飾されたガイドrnaを使用する高特異性ゲノム編集
EP3464323B1 (en) Peptides and nanoparticles for intracellular delivery of genome-editing molecules
AU2020201465A1 (en) Using truncated guide rnas (tru-grnas) to increase specificity for rna-guided genome editing
JP2022524435A5 (cg-RX-API-DMAC7.html)
EP3277816A1 (en) Crispr/cas-related methods and compositions for treating duchenne muscular dystrophy and becker muscular dystrophy
EP4399294A1 (en) Guide rnas with chemical modification for prime editing
US20250257342A1 (en) Peptides and nanoparticles for intracellular delivery of genome-editing molecules
KR20210134000A (ko) Rna-가이드된 엔도뉴클레아제를 사용한 dna 통합을 위한 개선된 방법
RU2020100919A (ru) СПОСОБ НОКАУТИРОВАНИЯ ГЕНА-МИШЕНИ В T-КЛЕТКЕ IN VITRO И crRNA, ПРИМЕНЯЕМАЯ В ДАННОМ СПОСОБЕ
JP2024533448A (ja) 化学修飾を有するガイドrnaを使用する方法
CA3253302A1 (en) CELL COMPOSITIONS AND ENGINEERING METHODS
US20250115903A1 (en) Compositions and methods for editing genomes
HK40064529A (en) Peptides and nanoparticles for intracellular delivery of genome-editing molecules
CA3230928A1 (en) Methods for using guide rnas with chemical modifications
HK40006957B (en) Peptides and nanoparticles for intracellular delivery of genome-editing molecules